EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseOpen Access · CC BY-NC 3.0

Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis

Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim

Clinical and Molecular Hepatology · 2023

DOI: 10.3350/cmh.2023.0131 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Clinical and Molecular Hepatology, 2023. Verfasst von Ha Il Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology, Hanyang University College of Medicine, Guri, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Catheter Ablation, Radiofrequency Ablation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Korean Association for the Study of the Liver.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: There is no clear consensus on the relative ranking of interventional and radiation techniques with indications similar to those of radiofrequency ablation (RFA) for the treatment of early hepatocellular carcinoma (HCC). We used a network meta-analysis to compare the efficacy of non-surgical treatments for early HCC.

Methods

We searched databases for randomized trials assessing the efficacy of loco-regional treatments for HCCs ≤5 cm with no extrahepatic spread or portal invasion. The primary outcome was the pooled hazard ratio (HR) for overall survival (OS), and secondary outcomes included overall and local progression-free survival (PFS). A frequentist network meta-analysis was performed, and the relative ranking of therapies was assessed with P-scores.

Results

Nineteen studies comparing 11 different strategies in 2,793 patients were included. Chemoembolization plus RFA improved OS better than RFA alone (HR 0.52, 95% confidence interval [CI] 0.33–0.82; P-score=0.951). Cryoablation, microwave ablation, laser ablation, and proton beam therapy had similar effects on OS compared with RFA. For overall PFS, but not local PFS, only chemoembolization plus RFA performed significantly better than RFA (HR 0.61, 95% CI 0.42–0.88; P-score=0.964). Injection of percutaneous ethanol or acetic acid was significantly less effective than RFA for all measured outcomes, while no differences in progression outcomes were identified for other therapies included in the network.

Conclusions

Our results suggest that chemoembolization combined with RFA is the best option for local treatment of early HCC. Cases with potential contraindications for RFA may benefit from a tailored approach using thermal or radiation modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCatheter AblationRadiofrequency AblationChemoembolization, TherapeuticHumansTreatment OutcomeRetrospective Studies

Stichwörter der Autor:innen

Hepatocellular carcinomaLoco-regional treatmentNetwork meta-analysisRadiofrequency ablationSurvival

Autor:innen und Institutionen

  • Gastroenterology and Hepatology, Hanyang University College of Medicine, Guri, Korea.
  • Biostatistics, College of Medicine, Korea University, Seoul, Korea.
  • Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Korean Association for the Study of the Liver
  • Korean Liver Foundation
  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Kim, H. I., An, J., Han, S., & Shim, J. H. (2023). Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2023.0131

Vancouver

Kim HI, An J, Han S, Shim JH. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis. Clinical and Molecular Hepatology. 2023. doi:10.3350/cmh.2023.0131

BibTeX
@article{Kim2023,
  author = {Kim, Ha Il and An, Jihyun and Han, Seungbong and Shim, Ju Hyun},
  title = {Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis},
  journal = {Clinical and Molecular Hepatology},
  year = {2023},
  doi = {10.3350/cmh.2023.0131}
}
Kostenlos starten →